Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

156 III. SUBSTANCES OF ABUSEKing, V. L., Brooner, R. K., Kidorf, M. S., Stoller, K. B., & Mirsky, A. F. (1999). Attentiondeficit hyperactivity disorder and treatment outcome in opioid abusers enteringtreatment. J Nerv Ment Dis, 187(8), 487–495.Kleber, H. D., Riordan, C. E., Rounsaville, B., Kosten, T., Charney, D., Gaspari, J., etal. (1985). Clonidine in outpatient detoxification from methadone maintenance.Arch Gen Psychiatry, 42, 391–394.Koob, G. F., & Bloom, F. E. (1988). Cellular and molecular mechanisms of drugdependence. Science, 242, 715–723.Martin, W. R., & Jasinski, D. R. (1969). Physiological parameters of morphine dependencein men: Tolerance, early abstinence, protracted abstinence. J Psychiatr Res, 7,9–17.Mattick, R. P., Ali, R., White, J. M., O’Brien, S., Wolk, S., & Danz, C. (2003).Buprenorphine versus methadone maintenance therapy: A randomized doubleblind trial with 405 opioid-dependent patients. Addiction, 98, 441–452.Mirin, S. M., Weiss, R. D., Michael, J., & Griffin, M. L. (1989). Psychopathology insubstance abusers: Diagnosis and treatment. Am J Drug Alcohol Abuse, 14, 139–157.O’Brein, W. B., & Biase, D. V. (1981). The therapeutic community: The family-milieuapproach to recovery. In J. H. Lowinson & P. Ruiz (Eds.), Substance abuse: Clinicalproblems and perspectives (pp. 303–316). Baltimore: Williams & Wilkins.O’Connor, P. G., Waugh, M. E., Carroll, K. M., Rounsaville, B. J., Diagkogiannis, I. A.,& Schottenfeld, R. S. (1995). Primary care-based ambulatory opioid detoxification:The results of a clinical trial. J Gen Intern Med, 10, 255–260.Otto, K. C. (2003). Acupuncture and substance abuse: A synopsis, with indications forfurther research. Am J Addict, 12(1), 43–51.Petitjean, S., Stohler, R., Deglon, J. J., Livoti, S., Waldvogel, D., Uehlinger, C., &Ladenwig, D. (2001). Double-blind randomized trial of buprenorphine and methadonein opiate dependence. Drug Alcohol Depend, 62, 97–104.Rabinowitz, J., Cohen, H., & Atias, S. (2002). Outcome of naltrexone maintenance followingultra rapid opiate detoxification versus intensive inpatient detoxification.Am J Addict, 11(1), 52–56.Robles, E., Stitzer, M. I., Strain, E. C., Bigelow, G. E., & Silverman, K. (2002).Voucher-based reinforcement of opiate abstinence during methadone detoxification.Drug Alcohol Depend, 65(2), 179–189.Rosenthal, M. S. (1989). The therapeutic community: Exploring the boundaries. Br JAddict, 84, 141–150.Senay, E. C. (1983). Substance abuse disorders in clinical practice. Littleton, MA: JohnWright/PSG.Spencer, L., & Gregory, M. (1989). Clonidine transdermal patches for use in outpatientopiate withdrawal. J Subst Abuse, 6, 113–117.Substance Abuse and Mental Health Services Administration. (1995, November). Preliminaryestimates from the Drug Abuse Warning Network (Advance Report No. 11).Washington, DC: Author.Wilford, B. B. (1981). Drug abuse for the primary care physician. Chicago: AmericanMedical Association.Woody, G. E., McLellan, A. T., Luborsky, L., & O’Brien, C. P. (1985). Sociopathy andpsychotherapy outcome. Arch Gen Psychiatry, 42, 1081–1086.